Professor, Medicine, Perelman School of Medicine
Gastroenterology
Dr. Anil K. Rustgi, MD
|
|
Give Review
Anil Rustgi works in the field of Gastroenterology. He went to medical school at Duke University School of Medicine. Duke University School of Medicine is a top medical college. Duke University School of Medicine has a rank of 8 in research and a 29 in primary care He over the years received 26 awards: "Research Mentor Award", "The Ruth C. Brufsky Award for Excellence in Research in Pancreatic Cancer", "Distinguished Achievement Award", "Distinguished Mentor Award", "Arthur Asbury Outstanding Faculty Mentor Award", "CMS Meaningful Use Stage 1 Certification", "Fellow (AGAF)", "Research Professorship (competitive selection)", "Selected (approved by HHS Dept.)", "Elected", "Faculty Award", "Top Docs in the United States", "Elected Member", "Investigator Award", "Young Investigator Award for Research Achievement in Gastroenterology", "Funderberg Research Award in Gastric Cancer Biology", "Jr. Faculty Research Award", "Fiterman Basic Science Research Award (Walter B. Cannon Award)", "Clinical Investigator Award", "Fellowship", "Winner for Clinical Study", "Trent Prize in the History of Medicine", "Davison Scholarship for Study of Infectious Diseases in Brazil", "Department Honors in Molecular Biophysics and Biochemistry", "Masters Service Award" and "Super Doctor". Anil K. Rustgi is a published MD as well. He has 101 publications published. The latest was: A randomized phase II dose-response exercise trial among Colon Cancer Survivors: Purpose, Study Design, methods, and recruitment results. He is registered with Medicare and accepts Medicare payments.
Publications
- O-010 Novel Regulation of Autophagy and Intestinal Homeostasis Via mRNA Binding Protein IMP1.
- A randomized phase II dose-response exercise trial among Colon Cancer Survivors: Purpose, Study Design, methods, and recruitment results.
- Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer.
- A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis.
- SOX15 governs transcription in human stratified epithelia and a subset of esophageal adenocarcinomas.
- Loss of Stromal IMP1 Promotes a Tumorigenic Microenvironment in the Colon.
- Racial Disparities in Colorectal Cancer Survival: Is Elimination of Variation in Care the Cure?
- Multiple gastroIntestinal polyps in patients treated with BRAF inhibitors.
- PRMT5 Is Required for Lymphomagenesis Triggered by Multiple Oncogenic Drivers.
- WNT10a promotes an invasive and self-renewing phenotype in esophageal squamous cell carcinoma.
- Gremlin 1 identifies a skeletal stem cell with bone, cartilage, and reticular stromal potential.
- Mark warren babyatsky, MD (june 29, 1959-august 25, 2014).
- Cellular senescence checkpoint function determines differential Notch1-dependent oncogenic and tumor-suppressor activities.
- Barrett's Esophagus Translational Research Network (BETRNet): The Pivotal Role of Multi-institutional Collaboration in Esophageal Adenocarcinoma Research.
- Modeling human gastrointestinal inflammatory diseases using microphysiological culture Systems.
- The efficacy of screening colonoscopy.
- Triggering ubiquitination of IFNAR1 protects tissues from inflammatory injury.
- Familial pancreatic Cancer: genetic advances.
- The house of gastroIntestinal medicine: how academic medical centers can build a sustainable economic clinical model.
- LIN28B promotes growth and tumorigenesis of the Intestinal epithelium via Let-7.
- EGFR Inhibition Promotes an Aggressive Invasion Pattern Mediated by Mesenchymal-like Tumor Cells within Squamous Cell Carcinomas.
- IMP1 promotes tumor growth, dissemination and a tumor-initiating cell phenotype in Colorectal cancer cell xenografts.
- Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett's Esophagus: results from a US Multicenter Con...
- BRAF: A Driver of the Serrated Pathway in Colon Cancer.
- Isolation, culture and genetic manipulation of mouse pancreatic ductal cells.
- A historical perspective on clinical advances in pancreatic Diseases.
- ERK2-regulated TIMP1 Induces Hyperproliferation of K-Ras (G12D)-Transformed Pancreatic Ductal Cells.
- Sox2 cooperates with inflammation-mediated stat3 activation in the malignant transformation of foregut Basal progenitor cells.
- Advances in acute and chronic Pancreatitis: from development to inflammation and repair.
- Matricellular proteins: priming the tumour microenvironment for Cancer development and metastasis.
- Local hypersensitivity reaction in transgenic mice with squamous epithelial IL-5 overexpression provides a novel model of eosinophilic oesophagitis.
- Elk-1 phosphorylated at threonine-417 is present in diverse Cancers and correlates with differentiation grade of colonic adenocarcinoma.
- Optical Imaging of Periostin Enables Early Endoscopic Detection and Characterization of Esophageal Cancer in Mice.
- Constitutive K-RasG12D Activation of ERK2 Specifically Regulates 3D Invasion of Human Pancreatic Cancer Cells via MMP-1.
- Pancreatic ductal cells in development, regeneration, and neoplasia.
- Ionizing Radiation Enhances Esophageal Epithelial Cell Migration and Invasion Through a Paracrine Mechanism Involving Stromal-Derived Hepatocyte Growth Factor.
- The Fbx4 Tumor Suppressor Regulates Cyclin D1 Accumulation and Prevents Neoplastic Transformation.
- Development and characterization of an organotypic model of Barrett's Esophagus.
- Tobacco-specific carcinogen nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induces AKT activation in head and neck epithelia.
- Mentorship in Academic Medicine.
- Detecting and targeting mesenchymal-like subpopulations within squamous cell carcinomas.
- Remembrance of Things Past.
- Lin28b promotes colon Cancer progression and metastasis.
- Deletion of p120-Catenin Results in a Tumor Microenvironment with Inflammation and Cancer that Establishes It as a Tumor Suppressor Gene.
- Systemic activation of K-ras rapidly induces gastric hyperplasia and metaplasia in mice.
- IMP-1 displays cross-talk with K-Ras and modulates colon Cancer cell survival through the novel proapoptotic protein CYFIP2.
- Adult pancreatic acinar cells dedifferentiate to an embryonic progenitor phenotype with concomitant activation of a senescence programme that is present in chronic pan...
- K-ras mutation targeted to gastric tissue progenitor cells results in chronic inflammation, an altered microenvironment, and progression to intraepithelial neoplasia.
- Nuclear cyclin D1/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferase.
- SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome.
- Gastroenterology: a year of growth and change.
- The role of the miR-200 family in epithelial-mesenchymal transition.
- Periostin, a cell adhesion molecule, facilitates invasion in the tumor microenvironment and annotates a novel tumor-invasive signature in esophageal Cancer.
- Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion.
- Colon Cancer: an update and future directions.
- Notch1 functions as a tumor suppressor in a model of K-ras-induced pancreatic ductal adenocarcinoma.
- Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription f...
- The pancreatic and Duodenal homeobox protein PDX-1 regulates the ductal specific keratin 19 through the degradation of MEIS1 and DNA binding.
- Dexamethasone treatment induces the reprogramming of pancreatic acinar cells to hepatocytes and ductal cells.
- Isoform-specific upregulation of palladin in human and murine pancreas tumors.
- Identification of a bone marrow-derived mesenchymal progenitor cell subset that can contribute to the gastric epithelium.
- Pancreatic ductal morphogenesis and the Pdx1 homeodomain transcription factor.
- SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas.
- Differential secreted proteome approach in murine model for candidate biomarker discovery in colon Cancer.
- Cyclin D1 overexpression increases susceptibility to 4-nitroquinoline-1-oxide-induced dysplasia and neoplasia in murine squamous oral epithelium.
- Gastroenterology year in review.
- The diabetes gene Pdx1 regulates the transcriptional network of pancreatic endocrine progenitor cells in mice.
- Stable isotope dilution multidimensional liquid chromatography-tandem mass spectrometry for pancreatic Cancer serum biomarker discovery.
- Low frequency of MLL3 mutations in Colorectal carcinoma.
- Endothelin-3 stimulates survival of goblet cells in organotypic cultures of fetal human colonic epithelium.
- Pancreatic Cancer: translating lessons from mouse models and hereditary syndromes.
- A subpopulation of mouse esophageal basal cells has properties of stem cells with the capacity for self-renewal and lineage specification.
- Cleavage of MCM2 licensing protein fosters senescence in human keratinocytes.
- Bortezomib induces apoptosis in esophageal squamous cell carcinoma cells through activation of the p38 mitogen-activated protein kinase pathway.
- Gastroenterology 2007 in review.
- Mutations in Fbx4 inhibit dimerization of the SCF(Fbx4) ligase and contribute to cyclin D1 overexpression in human Cancer.
- Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian Cancer.
- Parvin-beta inhibits breast Cancer tumorigenicity and promotes CDK9-mediated peroxisome proliferator-activated receptor gamma 1 phosphorylation.
- Cdx1 and c-Myc foster the initiation of transdifferentiation of the normal esophageal squamous epithelium toward Barrett's Esophagus.
- Nuclear accumulation of cyclin D1 during S phase inhibits Cul4-dependent Cdt1 proteolysis and triggers p53-dependent DNA rereplication.
- The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces ...
- The genetics of hereditary colon Cancer.
- Cell cycle dependent and schedule-dependent antitumor effects of sorafenib combined with radiation.
- Epigenetic silencing of CDX2 is a feature of squamous esophageal Cancer.
- Advances and challenges in aeroDigestive epithelial cancer: meeting summary and research opportunities.
- Conflicts of interest and disclosures in publications.
- Common activation of canonical Wnt signaling in pancreatic adenocarcinoma.
- The PDX1 homeodomain transcription factor negatively regulates the pancreatic ductal cell-specific keratin 19 promoter.
- Models of esophageal carcinogenesis.
- The molecular pathogenesis of pancreatic Cancer: clarifying a complex circuitry.
- Tumorigenic conversion of primary human esophageal epithelial cells using oncogene combinations in the absence of exogenous Ras.
- Clinical trial resources on the internet must be designed to reach underrepresented minorities.
- Coordinated functions of E-cadherin and transforming growth factor beta receptor II in vitro and in vivo.
- N-cadherin and keratinocyte growth factor receptor mediate the functional interplay between Ki-RASG12V and p53V143A in promoting pancreatic cell migration, invasion, a...
- Barrett's Esophagus and its progression to adenocarcinoma.
- Pancreatic Cancer in mice and man: the Penn Workshop 2004.
- Creating oral squamous Cancer cells: a cellular model of oral-esophageal carcinogenesis.
- Cyclin D1 induction through IkappaB kinase beta/nuclear factor-kappaB pathway is responsible for arsenite-induced increased cell cycle G1-S phase transition in human k...
- Pancreatic Cancer: novel approaches to diagnosis and therapy.
- Characterization of proteins in human pancreatic Cancer serum using differential gel electrophoresis and tandem mass spectrometry.
Schools
Duke University School Of Medicine
Beth Israel Hospital Harvard Med School
Mass Genl Hospital Harvard Med School
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
- Gastroenterology
Accepted Insurances
Awards
- Research Mentor Award
- The Ruth C. Brufsky Award for Excellence in Research in Pancreatic Cancer
- Distinguished Achievement Award
- Distinguished Mentor Award
- Arthur Asbury Outstanding Faculty Mentor Award
- CMS Meaningful Use Stage 1 Certification
- Fellow (AGAF)
- Research Professorship (competitive selection)
- Selected (approved by HHS Dept.)
- Elected
- Faculty Award
- Top Docs in the United States
- Elected Member
- Investigator Award
- Young Investigator Award for Research Achievement in Gastroenterology
- Funderberg Research Award in Gastric Cancer Biology
- Jr. Faculty Research Award
- Fiterman Basic Science Research Award (Walter B. Cannon Award)
- Clinical Investigator Award
- Fellowship
- Winner for Clinical Study
- Trent Prize in the History of Medicine
- Davison Scholarship for Study of Infectious Diseases in Brazil
- Department Honors in Molecular Biophysics and Biochemistry
- Master’s Service Award
- Super Doctor
Education
-
Massachusetts General Hospital -
Beth Israel Deaconess Medical Center -
Duke University School of Medicine -
Yale University
Hospital
-
Hospital of the University of Pennsylvania -
Penn Presbyterian Medical Center
Drug Facts
| NPI NUMBER | 1609919588 | |
| NPPES Provider LastName | RUSTGI | |
| NPPES Provider FirstName | ANIL | |
| NPPES Provider ZIPCode | 191044863 | |
| NPPES Provider State | PA | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 17.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1609919588 |
| Last Name Of The Provider | RUSTGI |
| First Name Of The Provider | ANIL |
| View All |
Similar Doctors
|
|
Dr. Yogesh K. Govil, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel J. Sher, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory G. Ginsberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Oleh Haluszka, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey R. Greenspan, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raymond E. Joseph, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel A. Ringold, MD |
|
|
Dr. Nicholas T. Orfanidis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William H. Lipshutz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gail M. Porat, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patricia L. Kozuch, MD
This Doctor is OpenDoctor Recommended.
|